Category Archives: Stem Cell Clinics

Comprehensive Report on Canine Stem Cell Therapy Market Set to Witness Huge Growth by 2026 | VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,…

Canine Stem Cell Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

The global Canine Stem Cell Therapy Market size is expected to Expand at Significant CAGR of +4% during forecast period (2020-2026).

The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos

This report provides a detailed and analytical look at the various companies that are working to achieve a high market share in the global Canine Stem Cell Therapy market. Data is provided for the top and fastest growing segments. This report implements a balanced mix of primary and secondary research methodologies for analysis. Markets are categorized according to key criteria. To this end, the report includes a section dedicated to the company profile. This report will help you identify your needs, discover problem areas, discover better opportunities, and help all your organizations primary leadership processes. You can ensure the performance of your public relations efforts and monitor customer objections to stay one step ahead and limit losses.

Key Influence of the Canine Stem Cell Therapy Market:

Get up to 25 % Discount on this Premium Report @:

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Canine Stem Cell Therapy market. It focuses on the major points, which are necessary to make positive impacts on the market policies, international transactions, speculation, and supply demand in the global market.

Global Canine Stem Cell Therapy Market Segmentation:

Market Segmentation: By Type

Allogeneic Stem Cells Autologous Stem cells

Market Segmentation: By Application

Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Canine Stem Cell Therapy market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Canine Stem Cell Therapy market.

Table of Contents

Global Canine Stem Cell Therapy Market Research Report 2020 2026

Chapter 1 Canine Stem Cell Therapy Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Canine Stem Cell Therapy Market Forecast

Buy Exclusive Report @:

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith



+1 775 237 4147

Comprehensive Report on Canine Stem Cell Therapy Market Set to Witness Huge Growth by 2026 | VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus,…

Nancy Lane, MD: The State of Osteoarthritis and Osteoporosis – MD Magazine

Osteoarthritis and osteoporosis are common conditions in which millions of patients are affected worldwide. Despite the common nature of the diseases, patients are not often regularly scanned to see if they have 1 of them. Instead, they suffer pain and have an increased risk of fragility fractures and worse quality of life.

Nancy Lane, MD, of UC Davis Health is an expert in osteoarthritis and osteoporosis who spoke at the Congress of Clinical Rheumatology East 2020 meeting about the state of both diseases today. HCPLive had the opportunity to speak with Lane about the 2 spaces, popular agents for the treatments of the diseases, and why patients are being scanned regularly for the conditions.

HCPLive: Whats going on in the world of osteoarthritis right now?

Lane: It’s an exciting time in the space of osteoarthritis. There’s tremendous work being done in the basic science of the disease and there are some very exciting translational phase 2-type studies that are right now recruiting patients that are looking at agents that can stimulate the cartilage to grow and thicken, that can reduce the degradation and increase cartilage matrix formation. There are studies just reported where inhibitor seville 1 reduced joint replacements over 3.5 years by over 50% and a group of agents that by themselves don’t reverse or slow the course of the disease, but are an actual inhibitor of pain in the joint by a novel pathway of inhibiting nerve growth factor, that compound tanezumab may be available to our patients in the early part of next year.

So, those are some examples of the excitement in terms of new therapeutics. In addition, although I will not be spending a lot of time talking about this, there finally has been a way to get stem cells to turn into cartilage and grow cartilage. It’s a little bit complicated, but it requires some skeletal stem cells and then giving it a growth factor and a factor to inhibit new blood vessel formation, anti-VEGF, and cartilage has now been generated in a mouse where there’s been a defect. And if we can translate any of that to the clinic, we’re really going to be able to help our patients.

HCPLive: What agents are you most excited about?

Lane: Well to inhibit pain for a prolonged period of time, I’m excited about the inhibition of nerve growth factor of the tanezumab work. For the IL-1 inhibitor, the data are for canakinumab. The stem cell work is in its infancy and is being done out of Stanford.

HCPLive: Youre also an expert in osteoporosis. How do you individualize treatment for that condition?

Lane: Well, that’s a great question. We look at it in terms of patients who are at high risk for fracture and we try to prevent fractures by giving them long-acting bisphosphonates or other inhibitors. Then we have patients who present to us and they’ve already had fragility fractures. And for those patients I will emphasize starting them on an anabolic agent, either teriparatide, abaloparatide, or romosozumab followed then by a strong and resorptive agent to maintain that bone that they have gained and maintain their improved bone strength.

HCPLive: It’s interesting you bring up bisphosphonates. I was actually just looking at an abstract that was presented earlier today at the North American Young Rheumatologists Investigator Forum and the investigators noted how osteoporosis is a condition a lot of patients are not necessarily screened for. Why is that?

Lane: Well, that’s a great question. There’s been a sea change over the last 10 years. Ten years ago, many physicians had bone density machines in their office, and they would do the scans right there and interpret them. However, there was a change in reimbursement and it resulted in many of the bone density machines no longer being available, except in hospitals or in large clinics, which for some reason, has reduced physicians and healthcare providers interest in getting bone densities, and the result being less people are treated for their osteoporosis and then osteoporosis comes to the attention of the physician later when there’s a fragility fracture. That alone is a diagnosis of osteoporosis. But actually, screening and treating people at high risk, we’re lucky if we can do it, lucky if it’s done at age 65.

Now, the guidelines are very clear. All women should have a bone density scan at age 65 and all men at the age of 70. Women below the age of 65 should if they’ve had a fragility fracture or have significant risk factors. So, all women for the most part should be screened by age 65 and all men at age 70, but that’s rarely happening today. As a result, we are seeing more fragility fractures in our population.

HCPLive: How detrimental can that be?

Lane: Well, the first fracture by itself, say its a vertebral fracture, may not be detrimental. But 1 fracture significantly increase your risk of another fracture and another fracture, at which point, with the vertebral fractures, you’re losing height, you’re bent over, and your quality of life goes down. So, we really need to try to recognize that first fracture and get it treated. If we can’t do it before the fracture, then we definitely need to do it when they first have a fragility fracture.

HCPLive: How are you able to do that without the machinery?

Lane: Well, it’s difficult, but the patients who have a clinical or painful vertebral fracture, or an osteoporotic fracture fragility fracture by say, falling from a high standing height. Hopefully they will get referred to fracture liaison services or to doctors that will work them up. Otherwise, if we don’t catch them at the first couple of fractures, that’s a bad position to be in. So, we all have to be on the lookout for these patients. Rheumatologists are very good at identifying these patients. We see older patients with other musculoskeletal ailments and rheumatologists tend to be pretty vigilant about getting bone densities, assessing our patients, treating them, and following them.

HCPLive: Is there anything else you would like to add about osteoarthritis or osteoporosis that is happening right now?

Lane: The most important thing is that physicians recognize the need for every woman over 65 and every male over 70 to have a bone density scan. If they’re treated, remember after 3 years to check their bone densities to see if they’ve improved, or if they haven’t fractured and they’ve been on intravenous bisphosphonates, then they should have a drug holiday. If they’ve been on oral for 5 years and they arent having fractures and their bone density is good, they should be on a drug holiday and remember to follow them. Remember to see them in about 2-3 years and reassess them because many patients after these holidays slip back into needing therapy.

Another very important thing to remember is osteoporosis is like any chronic disease of aging. Once you have it, you always have it and your risk of fracture may change but you need to assess for it the rest of a patient’s life.

The rest is here:
Nancy Lane, MD: The State of Osteoarthritis and Osteoporosis – MD Magazine

NK Cell Therapy and Stem Cell Therapy Market Research, Clinical Study and Business Guidelines till 2026 | Chipscreen Biosciences Innate Pharma SA …

Global NK Cell Therapy and Stem Cell Therapy Market Research Report presents the overview and in depth study of worldwide NK Cell Therapy and Stem Cell Therapy Market for achieving throughout understanding and business intelligence of the market with the Financial & Industrial Analysis of key players, companies, region, types, applications and its future scope in the industry till 2027.

The NK Cell Therapy and Stem Cell Therapy market revenue was valued at xx.xx Million USD in 2020 and it is expected to reach xx.xx Million USD in 2027, with a CAGR of x.x% during 2020-2027. Based on the NK Cell Therapy and Stem Cell Therapy industrial chain, this report mainly elaborates the definition, types, applications and major players of NK Cell Therapy and Stem Cell Therapy market in details.

Get Sample Brochure(PDF) of NK Cell Therapy and Stem Cell Therapy market at:

Deep analysis about market status (2014-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2024), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included.

From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the NK Cell Therapy and Stem Cell Therapy market.

The NK Cell Therapy and Stem Cell Therapy market can be split based on product types, major applications, and important regions.

Major Players in NK Cell Therapy and Stem Cell Therapy market are: Chipscreen Biosciences Innate Pharma SA Osiris Therapeutics Chiesi Pharmaceuticals Molmed JCR Pharmaceutical Altor BioScience Corporation Affimed NV Takeda Pharmaceutical Pharmicell Medi-post NuVasive Anterogen

Most important types of NK Cell Therapy and Stem Cell Therapy products covered in this report are: NK Cell Therapy Stem Cell Therapy

Most widely used downstream fields of NK Cell Therapy and Stem Cell Therapy market covered in this report are: Hospital & clinics Regenerative medicine centers Diagnostic centers Research institutes Others

Major Regions that plays a vital role in NK Cell Therapy and Stem Cell Therapy market are: North America Europe China Japan Middle East & Africa India South America Others

Request to Purchase the Full NK Cell Therapy and Stem Cell Therapy market report at:

There are 13 Chapters to thoroughly display the NK Cell Therapy and Stem Cell Therapy market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: NK Cell Therapy and Stem Cell Therapy Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: NK Cell Therapy and Stem Cell Therapy Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market

Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of NK Cell Therapy and Stem Cell Therapy.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of NK Cell Therapy and Stem Cell Therapy.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of NK Cell Therapy and Stem Cell Therapy by Regions (2014-2020).

Chapter 6: NK Cell Therapy and Stem Cell Therapy Production, Consumption, Export and Import by Regions (2014-2020).

Chapter 7: NK Cell Therapy and Stem Cell Therapy Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of NK Cell Therapy and Stem Cell Therapy.

Chapter 9: NK Cell Therapy and Stem Cell Therapy Market Analysis and Forecast by Type and Application (2020-2024).

Chapter 10: Market Analysis and Forecast by Regions (2020-2024).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

About Us Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us Gasper James 304, S Jones Blvd, Las Vegas, NV 89107, USA US Toll Free +18666051052 Email: [emailprotected] Web:

Original post:
NK Cell Therapy and Stem Cell Therapy Market Research, Clinical Study and Business Guidelines till 2026 | Chipscreen Biosciences Innate Pharma SA …

Serving every person in the Summit County community – Summit Daily News

Panorama Summit Orthopedics has moved into its brand new, permanent clinic where it can continue to provide top notch orthopedic care to the entire community in a more spacious setting.

The number one goal of our practice from the start is to take care of this community, and that means all people, said Dr. Aaron Black, a sports medicine and orthopedic trauma specialist at Panorama Summit Orthopedics who has been with the Summit County practice since it opened. We dont turn anybody away. Were a top rate facility thats easily accessible and were here to take care of the entire community.

The entire Panorama Summit Orthopedics team knows and understands that being there for the community means committing to patients by providing same day appointments, timeliness in authorizing procedures, communication, efficiency, friendliness and follow-through, said Amy Manske, director of operations.

We are here for them to help them feel better so they can do more, she said.

Open in Frisco

With the completion of its brand new clinic on School Drive in Frisco, Panorama Summit Orthopedics is now able to offer more appointments and longer hours. This is especially helpful during COVID-19 thanks to a nearly 300% increase in the number of office exam rooms.

We went from seven rooms in the old office to 20, Dr. Black said. This facility also has a lot more space, which gives us a better ability to socially distance.

The new building also offers X-ray imaging and direct access to physical therapy services. Theres a procedure suite focusing on orthopedic biologics such as platelet-rich plasma and stem cell injections, as well as other small in-office procedures.

Its a really beautiful building and a much nicer facility with a lot more space, Dr. Black said of the practices new home.

Inclusive care

Panorama Summit Orthopedics believes that all treatment decisions shouldnt have anything to do with a patients insurance status or ability to pay. Dr. Black said this belief is also how hes ethically driven as a physician.

My goal has never been to look at how people pay, he said. Regardless of where people come from or what they do for a living, I know were taking care of the entire community and trying to make the right decisions for people.

Walk-in OrthoCare Clinic

Panorama Summit Orthopedics offers walk-in services for all orthopedic concerns except for spine (the practice is currently seeking a spine physician to add to its team). All walk-in patients will be seen by one of the clinics orthopedic surgeons.

This is a full orthopedic clinic visit, Dr. Black said. You see a doctor, and were there to perform a full history, imaging, small procedures, casting, splinting and small reductions.

Hours are Monday through Thursday from 4 to 6 p.m.; and 11 a.m. to 6 p.m. on Saturday.

On-site physical therapy

Physical therapy, which is an essential part of orthopaedic patients recovery, is now offered in the same building as the clinic. Dr. Black said just about every physical therapist in the county already has his cell phone number and can call anytime, but this new access adds another dimension to quality care.

Therapists can walk directly over and talk to us about patient questions, he said. If a wound looks funny or theres anything the therapist wants to talk about or show us, we can just walk over and look.

Added safety for staff and patients

Every patient who visits the Frisco clinic will get their temperature taken upon arrival. All patients and staff are required to wear face masks in the clinic (the clinic will provide masks for patients who need them).

Patients will also go straight to a private room to wait for their doctor rather than sit in a waiting room with others, Dr. Black said. All surfaces and equipment are also being frequently sanitized.

Weve done our best to keep everyone away from any interaction that isnt necessary, Dr. Black said. Some of my patients have said this feels like the safest place theyve been to in the county.

Read the original here:
Serving every person in the Summit County community – Summit Daily News

Coronavirus Disease (COVID-19) Impact Global Canine Stem Cell Therapy Market Report Top Companies like VETSTEM BIOPHARMA, Cell Therapy Sciences,…

Global Coronavirus pandemic has impacted all industries across the globe, Canine Stem Cell Therapy market being no exception. As Global economy heads towards major recession post 2009 crisis, Cognitive Market Research has published a recent study which meticulously studies impact of this crisis on Global Canine Stem Cell Therapy market and suggests possible measures to curtail them. This press release is a snapshot of research study and further information can be gathered by accessing complete report. To Contact Research Advisor Mail us @ [emailprotected] or call us on +1-312-376-8303.

The research report on global Canine Stem Cell Therapy market as well as industry is a detailed study that provides detailed information of major key players, product types & applications/end-users; historical figures, region analysis, market drivers/opportunities & restraints forecast scenarios, strategic planning, and a precise section for the effect of Covid-19 on the market. Our research analysts intensively determine the significant outlook of the global Canine Stem Cell Therapy market study with regard to primary & secondary data and they have represented it in the form of graphs, pie charts, tables & other pictorial representations for better understanding.

Allogeneic Stem Cells, Autologous Stem cells are some of the key types of market. All the type segments have been analyzed based on present and future trends and the market is estimated from 2020 to 2027. Based on the application segment, the global market can be classified into Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes . The analysis of application segment will help to analyze the demand for market across different end-use industries.

Request Free Sample Copy of Canine Stem Cell Therapy Market Research [emailprotected]

Amid the COVID-19 pandemic, the industry is witnessing a major change in operations.Some of the key players include VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet . key players are changing their recruitment practices to comply with the social distancing norms enforced across several regions to mitigate the risk of infection. Additionally, companies are emphasizing on using advanced recruiting solutions and digital assets to avoid in-person meetings. Advanced technologies and manufacturing process are expected to play a decisive role in influencing the competitiveness of the market players.

Regional Analysis for Canine Stem Cell Therapy Market: North America (United States, Canada) Europe (Germany, Spain, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, India, Australia, and South Korea) Latin America (Brazil, Mexico, etc.) The Middle East and Africa (GCC and South Africa)

Get A Free Sample of Canine Stem Cell Therapy Market Report:

NOTE: Whole world is experiencing the impact of Covid-19 pandemic due to its increasing spread hence, the report comprises of an up to date scenario of the Canine Stem Cell Therapy market report. Research analyst team of our company is understanding & reviewing the Covid19 Impact on Market and all the necessary areas of the market that have been altered due to the change caused by Covid19 impact. Get in touch with us for more precise/in-depth information of the Canine Stem Cell Therapy market.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Canine Stem Cell Therapy Market Report 2020 (Coronavirus Impact Analysis on Canine Stem Cell Therapy Market)

At the end of May, many states began lifting lockdown restrictions and reopening in order to revive their economies, despite warnings that it was still too early. As a result, by mid-July, around 33 states were reporting higher rates of new cases compared to the previous week with only three states reporting declining rates. Due to this Covid-19 pandemic, there has been disruptions in the supply chain which have made end-use businesses realize destructive in the manufacturing and business process. During this lockdown period, the plastic packaging helps the products to have longer shelf life as the public would not be able to buy new replacements for the expired products because most of the production units are closed.

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market. Contact Us: +1-312-376-8303 Email: [emailprotected] Web:

Read more from the original source:
Coronavirus Disease (COVID-19) Impact Global Canine Stem Cell Therapy Market Report Top Companies like VETSTEM BIOPHARMA, Cell Therapy Sciences,…

Clinics ‘peddling false hope for autism with potentially hazardous 14,000 cell therapy’ – Mirror Online

Clinics have been accused of peddling false hope to parents of autistic children with potentially hazardous treatment.

A Sunday People probe found dozens of private firms charging up to 14,000 for stem cell therapy, claiming it provides a whole range of benefits.

Clinics insist the treatment in which donor cells are fed into a patients bloodstream via a drip can help improve youngsters social skills, speech and concentration.

But there are counter-claims that the therapy is unproven, could be distressing for children and even cause them more harm than good.

One mum blasted adverts for it as horrifying while other parents who forked out huge sums of cash complained it had little effect.

One called the therapy a 99 per cent failure and another said: I spent a ton of money on my two kids and nothing happened.

Professor Richard Mills, consultant for non-profit AT-Autism, said: Stem cell therapy is regarded within the medical community as potentially quite hazardous and there isnt so far a reliable evidence base that would cause it to be recommended.

It is controversial and experimental and Im not aware of any independent studies which prove it works.

Prof Mills said parents should see the high costs, the absence of regulated independent trials and testimonials as red flags of caution.

He added there were also huge ethical issues linked to treating children who may lack the capacity to consent to it.

He said: Using an intravenous injection, an infusion of fluid goes into the brain, which is unpleasant at best and may be highly distressing and traumatic for an autistic child.

One in every 100 kids in the UK has some form of autism, for which there is no medical cure.

The clinics we found work on the disputed premise that autism is a neurological disorder with clear causes that can be altered by intervention.

Most say stem cells, which can develop into other types of bodily cells and renew themselves, will have a reparative effect on the brain.

Stem cells are approved for treating some blood conditions, skin grafts and cornea repairs but remain unproven in regard to autism.

Only after full clinical trials can procedures be declared safe and better than existing treatments.

Prof Mills went on: These practitioners attempt to interfere with the core symptoms of autism, as they put it, but the National Institute for Health and Care Excellence has said there are no proven ways of altering this.

The Autism Regenerative Centre in Marylebone, central London, claims to have given therapy to over 500 children since 2014 without complications and says 80 per cent of them showed improvement.

An online ad for the private clinic says its treatments pass beyond the limitations of conventional therapies. We found further clinics around the world advertising in English and welcoming patients of all nationalities.

Swiss Medica features an online testimonial from a British family whose autistic child was treated at its premises in Goldach, Switzerland.

The online clip shows Paul from Reading saying the treatment in the UK is not what we liked for his three-year-old autistic son, but that the family were now feeling more optimistic.

The Swiss clinics website claims conventional treatment methods for autism only smooth out the specific symptoms, targeting one or two of them, whereas stem cell therapy is an entirely new tool.

The Stem Cell Institute in Panama charges between 10,000 and 13,000 for four-day packages for children.

It says the therapy decreases inflammation in the brain which may alleviate autism symptoms.

German International Clinic in Frankfurt charges more than 14,000 for the procedure, which it says will be effective for just three to eight months and recommends follow-up sessions.

It lists improved communication ability and memory as benefits.

But Brit mum Emma Dalmayne, whose children Damien, 12, and Skylar, seven, are autistic, was disgusted by the ads.

Emma, 44, who is autistic herself and runs the Autistic Inclusive Meets group, said: Its horrifying that parents of vulnerable children are being presented with a medical procedure thats not scientifically proven.

There has to be regulation to stop this. Emma, of Woolwich, south-east London, begged families to invest in occupational and speech therapies instead.

She warned: If you go down the pseudo-science route, youll be encouraged to part with huge sums of money that could otherwise go towards a proven therapy.

One US mum who spent 30,000 on treatment for her two kids in Mexico with no results said she believed stem cell therapy was a scam.

The woman, a 52-year-old nurse from New York who took out loans to fund the treatment, was taken in by online testimonials.

But she said: Nothing happened, nothing at all. Its a money-maker there are a lot of desperate people out there.The National Autistic Society accused firms of exploiting parents.

Director of external affairs Jane Harris said she was not aware of any stem cell trials for autism, and added: Private companies are taking advantage of autistic people and their families, asking them to pay for unproven and even dangerous treatments.

Dr Jon Goldin, vice chair of the Child and Adolescent faculty at the Royal College of Psychiatrists, said: There is currently no known cure for autism nor is there any scientific evidence that stem cells can be used safely and effectively as a treatment.

Labour MP Jonathan Reynolds, vice chair of the All Party Parliamentary Group on autism and father of an autistic son, said: It is incredibly worrying to hear that people might be being exploited when they are in such a vulnerable position.

Go here to read the rest:
Clinics ‘peddling false hope for autism with potentially hazardous 14,000 cell therapy’ – Mirror Online

Global Rheumatoid Arthritis Stem Cell Therapy Market Dynamics, Forecast, Analysis and Supply Demand 2018 to 2028 – Scientect

The globalRheumatoid Arthritis Stem Cell Therapymarketstudy presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Rheumatoid Arthritis Stem Cell Therapy market player in a comprehensive way. Further, the Rheumatoid Arthritis Stem Cell Therapy market report emphasizes the adoption pattern of the Rheumatoid Arthritis Stem Cell Therapy across various industries. Request Sample Report The Rheumatoid Arthritis Stem Cell Therapy market report highlights the following players:The global market for rheumatoid arthritis stem cell therapy is highly fragmented. Examples of some of the key players operating in the global rheumatoid arthritis stem cell therapy market include Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, TiGenix and others.

The Rheumatoid Arthritis Stem Cell Therapy market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail. Important regions covered in the Rheumatoid Arthritis Stem Cell Therapy market report include:

North America (U.S., Canada) Latin America (Mexico, Brazil) Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX) Eastern Europe (Russia, Poland, Rest Of Eastern Europe) Asia Pacific Excluding Japan (China, India, Australia & New Zealand) Japan Middle East and Africa (GCC, S. Africa, Rest Of MEA)

The Rheumatoid Arthritis Stem Cell Therapy market report takes into consideration the following segments by treatment type:

Allogeneic Mesenchymal stem cells Bone marrow Transplant Adipose Tissue Stem Cells

The Rheumatoid Arthritis Stem Cell Therapy market report contain the following distribution channel:

Hospitals Ambulatory Surgical Centers Specialty Clinics Have Any Query? Ask our Industry Experts-

Buy the report at a discounted rate!!! Exclusive offer!!!

The Rheumatoid Arthritis Stem Cell Therapy market report offers a plethora of insights which include:

Changing consumption pattern among individuals globally. Historical and future progress of the global Rheumatoid Arthritis Stem Cell Therapy market. Region-wise and country-wise segmentation of the Rheumatoid Arthritis Stem Cell Therapy market to understand the revenue, and growth lookout in these areas. Accurate Year-on-Year growth of the global Rheumatoid Arthritis Stem Cell Therapy market. Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global Rheumatoid Arthritis Stem Cell Therapy market.

The Rheumatoid Arthritis Stem Cell Therapy market report answers important questions which include:

Which regulatory authorities have granted approval to the application of Rheumatoid Arthritis Stem Cell Therapy in Health industry? How will the global Rheumatoid Arthritis Stem Cell Therapy market grow over the forecast period? Which end use industry is set to become the leading consumer of Rheumatoid Arthritis Stem Cell Therapy by 2028? What manufacturing techniques are involved in the production of the Rheumatoid Arthritis Stem Cell Therapy? Which regions are the Rheumatoid Arthritis Stem Cell Therapy market players targeting to channelize their production portfolio? Get Full Access of the Report @

Pertinent aspects this study on the Rheumatoid Arthritis Stem Cell Therapy market tries to answer exhaustively are:

What is the forecast size (revenue/volumes) of the most lucrative regional market? What is the share of the dominant product/technology segment in the Rheumatoid Arthritis Stem Cell Therapy market? What regions are likely to witness sizable investments in research and development funding? What are Covid 19 implication on Rheumatoid Arthritis Stem Cell Therapy market and learn how businesses can respond, manage and mitigate the risks? Which countries will be the next destination for industry leaders in order to tap new revenue streams? Which new regulations might cause disruption in industry sentiments in near future? Which is the share of the dominant end user? Which region is expected to rise at the most dominant growth rate? Which technologies will have massive impact of new avenues in the Rheumatoid Arthritis Stem Cell Therapy market? Which key end-use industry trends are expected to shape the growth prospects of the Rheumatoid Arthritis Stem Cell Therapy market? What factors will promote new entrants in the Rheumatoid Arthritis Stem Cell Therapy market? What is the degree of fragmentation in the Rheumatoid Arthritis Stem Cell Therapy market, and will it increase in coming years? Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Continue reading here:
Global Rheumatoid Arthritis Stem Cell Therapy Market Dynamics, Forecast, Analysis and Supply Demand 2018 to 2028 – Scientect

Stem Cell Therapy Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025 – Express Journal

A detailed overview of Stem Cell Therapy market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Stem Cell Therapy market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included in this report.Increasing research on developing novel therapies and personalized medicines will foster stem cell therapy market growth. For instance, scientists are extensively researching on methods to regenerate healthy heart cells from placenta that can be used in patients after myocardial infarction. This discovery will help to cure patients suffering from cardiovascular diseases and reduce mortality rates. Researchers are further examining different aspects of stem cell therapy for its applications in neurological disorders. Thus, increasing R&D activities to promote developments in stem cell therapy will positively impact the industry growth.Rising geriatric population will positively influence the industry growth in coming years. Elderly people are susceptible to degenerative diseases such as Parkinson?s and Alzheimer?s disorders. Stem cell therapies offer several benefits over the conventional therapeutic methods that raises its preference for curing degenerative diseases. Recently developed stem cell therapies generate healthy cells by replacing the defective cells through minimally invasive techniques. Therefore, geriatric population rely on stem cell therapies that proves beneficial for the industry growth.Stem Cell Therapy Market will exceed USD 15 billion by 2025; as per a new research report.Request Sample Copy of this Report @ segment is anticipated to witness more than 9% growth over the forecast time frame. Substantial growth is attributed to rising accidents and trauma cases across the globe. Stem cell therapy is successfully applicable in treating bone-joint injuries that include spinal and fractured bone defects, ligament tendon, femoral head and osteogenesis imperfecta. Mesenchymal stem cell therapy is preferred in curing orthopedic diseases such as arthritis and osteoporosis due to its ability to differentiate into bones and cartilage. Above mentioned factors will surge segment growth.Clinics segment accounted for around 35% revenue share in 2018. Clinics are equipped with advanced medical equipment and skilled professionals that enables it to provide superior quality stem cell therapies. Clinics can deliver specialized stem cell treatment in areas such as cardiovascular, oncology or orthopedics that should prove beneficial for the segmental growth. However, as the treatments offered at clinics are expensive, that may have a short term impact on the segment growth. Allogenic stem cell therapy segment was valued around USD 3 billion in 2018 and is anticipated to expand substantially in near future. Allogenic transplant completely replaces host cells with donor cells. It also has the potential to eliminate viral reservoirs and genetic alterations. Therefore, allogenic stem cell therapies have been extensively utilized in providing treatment to patients suffering from leukemia and several other life threatening diseases. Thus, benefits offered by allogenic stem cell therapy will surge its demand, thereby propelling segment growth.Europe is anticipated to witness around 10% growth during analysis time frame. Substantial growth is attributed to increasing prevalence of chronic diseases in the region. Moreover, the regulatory scenario for stem cell therapies is also improving gradually. Initially stringent regulations lowered the demand for stem cell therapies. However, as people started becoming aware regarding advantages associated with stem cell therapy, its adoption escalated. Above-mentioned factors fosters the regional growth.Prominent industry players operational in the stem cell therapy include Astellas Pharma, Cellectis, Celyad, ReNeuron Group, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, Novadip Biosciences, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, and Takeda Pharmaceuticals. These key players adopt several initiatives such mergers, acquisitions and new product launches to sustain market position. Besides these strategies, companies also undertake promotional strategies that enhance their sales. For instance, in June 2018, CESCA Therapeutics announced exhibition at Orthobiologic Institute?s ninth annual PRP and regenerative medicine symposium. This strategy was company?s promotional effort in order to gain attention of customers.Major Highlights from Table of contents are listed below for quick lookup into Stem Cell Therapy Market reportChapter 1. Methodology and Scope

View post:
Stem Cell Therapy Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025 – Express Journal

Stem Cell Therapy Market: Trends, Applications, Industry Competitive Analysis, Growth,Forecast: 2019 to 2029 – The Scarlet

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Stem Cell Therapy market.

Trusted Business Insights presents an updated and Latest Study on Stem Cell Therapy Market 2019-2029. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Stem Cell Therapy market during the forecast period (2019-2029). It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Abstract, Snapshot, Market Analysis & Market Definition: Stem Cell Therapy Market Industry / Sector Trends

Stem Cell Therapy Market size was valued at USD 7.8 billion in 2018 and is expected to witness 10.2% CAGR from 2019 to 2025.

U.S. Stem Cell Therapy Market Size, By Type, 2018 & 2025 (USD Million)

Rising prevalence of chronic diseases will positively impact the stem cell therapy market growth. Cardiovascular diseases, neurological disorders and other chronic conditions have resulted in high mortality over past few years. Conventional therapeutic methods and treatments are currently replaced due to lack of efficiency and efficacy. Recently developed stem cell therapies are capable of replacing defective cells to treat diseases that has reduced morbidity drastically. Therefore, people have now started relying on stem cell therapy that has long term positive effects.

Advancements in stem cell therapy in developed regions such as North America and Europe have boosted the industry growth. Since past few years, there have been several researches carried out for stem cell therapy. Currently developed stem cell therapies have shown positive outcomes in treatment of leukemia. Similarly, due to advancements in regenerative medicine, several other chronic conditions such as muscular dystrophy and cardiovascular diseases also have been cured. Aforementioned factors have surged the industry growth. However, high cost of allogenic stem cell therapy may hamper the industry growth to some extent.

Market Segmentation, Outlook & Regional Insights: Stem Cell Therapy Market

Stem Cell Therapy Market, By Type

Allogenic stem cell therapy segment held around 39% revenue share in 2018 and it is anticipated to grow substantially during analysis timeframe. Allogenic stem cell is available as off the shelf therapy and it is easily scalable that helps in providing treatment without delay. Moreover, the procedure includes culturing donor-derived immunocompetent cells that are highly effective in treatment of several diseases. Stem cells obtained in allogenic therapy are free of contaminating tumor cells. This reduces risk for disease recurrence that will surge its demand thereby, stimulating segment growth.

Autologous stem cell therapy segment is estimated to witness 10.1% growth over the forthcoming years. People usually prefer autologous stem cell therapy as it has minimum risk of immunological rejection. However, on introduction of allogenic stem cell therapy, demand for autologous stem cell therapy has declined as it is difficult to scale up. However, there are concerns regarding risk of cross contamination during large scale manufacturing of autologous stem cell lines that will impede segmental growth to some extent.

Stem Cell Therapy Market, By Application

Neurology segment was valued around USD 1.6 billion in 2018 and it is estimated that it will witness significant growth over the forthcoming years. Stem cells are used to replenish the disrupted neurological cells that helps in quick patient recovery. Pluripotent stem cells provide replacement for cells and tissues to treat Alzheimers, Parkinsons disease, cerebral palsy, amyotrophic lateral sclerosis and other neurodegenerative diseases. Thus, pivotal role of stem cells in treating life threatening neurological condition will escalate segment growth.

Cardiovascular segment will witness 10% growth over the analysis timeframe. Considerable segmental growth can be attributed to development in stem cell therapies that have enhanced recovery pace in patients suffering from cardiovascular diseases. Recently developed allogenic stem cell therapies are efficient and easily available that have reduced the mortality rates in cardiovascular patients. Above mentioned factors will propel cardiovascular segment growth in near future.

Germany Stem Cell Therapy Market Size, By Application, 2018 (USD Million)

Stem Cell Therapy Market, By End-users

Hospitals segment held over 56% revenue share in 2018 and it is anticipated to grow significantly in near future. Rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately. Associations with research and academic institutes further helps hospitals to upgrade its stem cell treatment offerings that positively impacts the segmental growth.

Clinics segment is expected to grow at around 10% during the forecast timeframe. Clinics specializing in providing stem cell therapies are well-equipped with advanced medical devices and superior quality reagents required for imparting stem cell therapies. However, as clinics offer specialized stem cell therapies, their treatment cost is much higher as compared to hospitals that may reduce its preference.

Stem Cell Therapy Market, By Region

North America stem cell therapy market held around 41.5% revenue share in 2018 and it is estimated to grow substantially in near future. Increasing adoption of novel stem cell therapies will prove beneficial for regional market growth. Moreover, favourable government initiatives have positive impact on the regional market growth. For instance, government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies enabling development in stem cell therapy. Above mentioned factors are expected to drive the North America market growth.

Asia Pacific stem cell therapy market is anticipated to witness 10.8% growth in near future owing to increasing awareness amongst people pertaining to benefits of advanced stem cell therapies. Additionally, favourable initiatives undertaken by several organizations will promote industry players to come up with innovative solutions. For instance, according to Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research. Thus, growing initiatives by organizations ensuring availability of new stem cell therapies will foster regional market growth.

Latin America Stem Cell Therapy Market Size, By Country, 2025 (USD Million)

Key Players, Recent Developments & Sector Viewpoints: Stem Cell Therapy Market

Key industry players in stem cell therapy market include Astellas Pharma Inc, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast Ltd, ReNeuron Group and Takeda Pharmaceuticals. Chief industry players implement several initiatives such as mergers and acquisitions to sustain market competition. Also, receiving approvals for stem cell therapy products from regulatory authorities fosters companys growth. For instance, in March 2018, European Commission approved Takedas Alofisel that is off-the-shelf stem cell therapy. Product approval will help company to gain competitive advantage and capture market share.

Stem Cell Therapy Industry Viewpoint

Stem cells industry can be traced back to 1950s. In 1959 first animals were made by in-vitro fertilization by preserving the stem cells. Till 2000, research was being carried out on stem cells to study its therapeutic effect. In 2000, fund allocations were made to research on cells derived from aborted human foetuses. In the same year, scientists derived human embryonic stem cells from the inner cell mass of blastocytes. Later, in 2010, clinical trials for human embryonic stem cell-based therapy were initiated. As technology progressed, stem cell therapy for treating cancer were developed. However, due to ethical issues, the use of stem cells for curing diseases witnessed slow growth for few years. But as the regulatory scenario changed, people started preferring stem cell therapies due to its better efficacy. Stem cell therapy is in developing stage and has numerous growth opportunities in developing economies with high prevalence of chronic diseases.

Key Insights Covered: Exhaustive Stem Cell Therapy Market 1. Market size (sales, revenue and growth rate) of Stem Cell Therapy industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Stem Cell Therapy industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Stem Cell Therapy industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Stem Cell Therapy industry.

Research Methodology: Stem Cell Therapy Market

Looking for more? Check out our repository for all available reports on Stem Cell Therapy in related sectors.

Quick Read Table of Contents of this Report @ Stem Cell Therapy Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19)

Trusted Business Insights Shelly Arnold Media & Marketing Executive Email Me For Any Clarifications Connect on LinkedIn Click to follow Trusted Business Insights LinkedIn for Market Data and Updates. US: +1 646 568 9797 UK: +44 330 808 0580

The rest is here:
Stem Cell Therapy Market: Trends, Applications, Industry Competitive Analysis, Growth,Forecast: 2019 to 2029 – The Scarlet

Global Canine Stem Cell Therapy Market 2027 Register a Xx% CAGR In Terms Of Revenue: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana…

Canine Stem Cell Therapy Market

DataIntelo, 12-08-2020: The research report on the Canine Stem Cell Therapy Market is a deep analysis of the market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. Experts have studied the historical data and compared it with the changing market situations. The report covers all the necessary information required by new entrants as well as the existing players to gain deeper insight.

Furthermore, the statistical survey in the report focuses on product specifications, costs, production capacities, marketing channels, and market players. Upstream raw materials, downstream demand analysis, and a list of end-user industries have been studied systematically, along with the suppliers in this market. The product flow and distribution channel have also been presented in this research report.

Get a PDF Copy of the Sample Report for Free @

The Major Manufacturers Covered in this Report: VETSTEM BIOPHARMA Cell Therapy Sciences Regeneus Aratana Therapeutics Medivet Biologics Okyanos Vetbiologics VetMatrix Magellan Stem Cells ANIMAL CELL THERAPIES Stemcellvet

The Research Study Focuses on:

By Types: Allogeneic Stem Cells Autologous Stem cells

By Applications: Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

By Regions:

To get this report at incredible Discounts, visit @

The Canine Stem Cell Therapy Market Report Consists of the Following Points:

Make an Inquiry of the Canine Stem Cell Therapy Market Report @

In conclusion, the Canine Stem Cell Therapy Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rate, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex Mathews Address: 500 East E Street, Ontario, CA 91764, United States. Phone No: USA: +1 909 545 6473 | IND: +91-7000061386 Email: [emailprotected] Website:

See the article here:
Global Canine Stem Cell Therapy Market 2027 Register a Xx% CAGR In Terms Of Revenue: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana…